What are the typical symptoms of Stevens-Johnson syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Most Likely Symptoms of Stevens-Johnson Syndrome

Stevens-Johnson syndrome presents with a characteristic triad: painful skin lesions with purpuric macules or flat atypical targets, severe mucous membrane involvement (eyes, mouth, nose, genitalia), and a preceding prodrome of fever and malaise, typically occurring 4-28 days after drug exposure. 1, 2

Prodromal Phase (Precedes Skin Eruption by Several Days)

  • Fever and malaise are prominent early features 1, 3
  • Upper respiratory tract symptoms resembling "flu-like" illness 1, 3
  • Cutaneous pain is a critical early warning sign that should immediately alert physicians to incipient epidermal necrolysis 1, 2
  • Ocular inflammation may develop before skin signs appear 1

Cutaneous Manifestations

Initial Lesion Characteristics

  • Earliest lesions appear as atypical targets and/or purpuric macules (dark red, flat lesions) 1, 2
  • Lesions are characterized by a dark red center surrounded by a pink ring 1, 2
  • Initial distribution: upper torso, proximal limbs, and face, then spreading to trunk and distal limbs 1, 2
  • Palms and soles involvement is often prominent 1, 2

Progression Pattern

  • Lesions expand and coalesce, reaching maximum extent 5-7 days after disease onset 1, 2
  • Large areas of confluent erythema develop in severe cases 1, 2
  • Lesional skin is exquisitely tender to touch 1, 2
  • Positive Nikolsky sign: minimal shearing forces or gentle lateral pressure causes epidermis to peel back 1, 2

Advanced Skin Findings

  • Flaccid blisters develop as necrotic epidermis separates from underlying dermis 1, 2, 4
  • Extensive necrolysis results in detachment of sheets of epidermis, leaving exposed, denuded dermis 1, 2
  • Denuded dermis exudes serum, becomes secondarily infected, and readily bleeds 1, 2

Mucous Membrane Involvement (Usually an Early Feature)

  • Erosive and hemorrhagic mucositis affecting multiple sites 1, 2, 5
  • Ocular involvement: purulent keratoconjunctivitis with eyelid edema develops early 5
  • Oral mucositis: mucosal erythema, blistering, and painful erosions that may require nasogastric tube feeding 1, 5
  • Genital and nasal mucosa involvement with erosions 1, 2
  • In some cases (particularly Mycoplasma-associated), predominantly mucous membrane involvement with minimal cutaneous lesions may occur 1, 2

Classification by Extent of Epidermal Detachment

  • SJS: <10% body surface area (BSA) detachment plus widespread purpuric macules or flat atypical targets 1, 2
  • SJS-TEN overlap: 10-30% BSA detachment plus widespread purpuric macules or flat atypical targets 1, 2
  • TEN: >30% BSA detachment 1, 2

Critical Clinical Pitfalls

  • Cutaneous pain preceding visible skin changes is a red flag that demands immediate evaluation 1, 2
  • The Nikolsky sign is helpful but not specific for SJS/TEN (also positive in pemphigus) 1, 2
  • Differentiation from erythema multiforme major is crucial: EMM has typical raised targets predominantly on limbs/extremities, while SJS has flat atypical targets more widely distributed 1
  • Document both extent of erythema AND epidermal detachment (detachable epidermis appears as dusky erythema before frank blistering) 1
  • Symptoms typically begin 4-28 days after drug initiation, which is critical for identifying the culprit medication 6, 3, 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Clinical Characteristics

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: An Update.

American journal of clinical dermatology, 2015

Research

Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.

Clinical reviews in allergy & immunology, 2018

Guideline

Distinguishing Features of DRESS Syndrome and SJS/TEN

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Diagnosis and Management of Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What is the management of Stevens-Johnson Syndrome (SJS)?
What is the treatment for Stevens-Johnson Syndrome?
What is the treatment approach for a patient diagnosed with Stevens-Johnson Syndrome (SJS)?
What is the treatment for Stevens-Johnson syndrome?
What are the symptoms, diagnosis, and treatment options for Steven Johnson's syndrome?
How should enterotoxigenic Escherichia coli (ETEC) diarrhea be managed in adults (including travelers) and children?
What diagnostic work‑up is indicated for a patient with visual aura, normal neurological evaluation, and isolated right‑ventricular and pulmonary‑artery dilation on echocardiography and cardiac CT without abnormal pulmonary venous return?
In an 8‑year‑old girl with poor concentration, hyperactivity, and only 5 hours of sleep (1 am–6 am), what is the most appropriate initial management: start melatonin 1 mg daily, perform a neurological examination, implement a structured sleep routine, or order blood tests for anemia?
What is the best medication for ventricular rate control in an elderly patient with diabetes mellitus, chronic kidney disease, peripheral arterial disease, a normal echocardiogram, and atrial fibrillation?
In a 50‑year‑old woman, what condition is indicated by a markedly increased blood urea nitrogen, mildly elevated serum creatinine, and a concurrent rise in hematocrit?
In an elderly patient with diabetes mellitus, chronic kidney disease, intermittent claudication, normal echocardiogram, no heart failure or chest pain, presenting with atrial fibrillation, which drug is best for ventricular rate control: digoxin, losartan, metoprolol, or diltiazem?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.